Výsledky vyhledávání - "K Villadiego"

Thermal Sensation Assessment at Different Types of Covered Outdoor Spaces in Barranquilla - Colombia

Publikováno v: IOP Conference Series: Earth and Environmental Science. 503:012009

The notion of comfort applies to productivity, hygiene and air treatment and to the dimensions of sustainability and energy saving. This research analyzes thermal sensation and microclimatic conditions at several outdoor spaces with different combina

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::eea93c878fab15b10a3c090db2b25397
https://doi.org/10.1088/1755-1315/503/1/012009

Zobrazit plný text záznamu

Carboplatin-gemcitabine treatment of patients with transitional cell carcinoma of the bladder and impaired renal function

Autor: E. Saigí, M. Nogué, R. Ibeas, Joan Carles, K. Villadiego, Miquel Domènech, Inmaculada Guasch, C. Pérez

Publikováno v: Oncology. 59(1)

Introduction: Bladder cancer is a frequently occurring tumour in Spain and usually affects elderly patients with renal impairment. The development of new combination therapies for such patients is thus of vital importance. Patients and Methods: Betwe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0143655967bfb699e43d792edd69d5f8
https://pubmed.ncbi.nlm.nih.gov/10895062

Zobrazit plný text záznamu

Final results of a prospective, observational study of the effectiveness of darbepoetin alfa administered every three weeks for the treatment of chemotherapy-induced anaemia in elderly patients

Autor: C. Pedro, M. Doménech, P. López, J. C. Bermejo, K. Villadiego, M. Constenla, César A. Rodríguez, G. Esquerdo, Pedro Sánchez-Rovira, J. A. Gasquet

Publikováno v: Journal of Clinical Oncology. 27:e20654-e20654

e20654 Background: Cancer incidence is increasing in elderly but specific treatment data in this population is not often available. The objectives of this study were to evaluate the effectiveness and safety of darbepoetin alfa (DA) administered once

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5f3ac7a9b04416570aed92537b12eaf2
https://doi.org/10.1200/jco.2009.27.15_suppl.e20654

Zobrazit plný text záznamu

Effectiveness of darbepoetin alfa administered every three weeks to elderly patients with chemotherapy-induced anemia

Autor: J. M. Gasent, Pedro Sánchez-Rovira, M. Doménech, J. C. Bermejo, C. de Pedro, J. A. Gasquet, K. Villadiego, César A. Rodríguez, P. Iturralde, P. López

Publikováno v: Journal of Clinical Oncology. 26:20690-20690

20690 Background: There are few studies specifically assessing, within routine clinical practice, the treatment of chemotherapy-induced anemia (CIA) in the elderly. The objective of this study was ...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a31775a14e016e5835d50861facf3d7c
https://doi.org/10.1200/jco.2008.26.15_suppl.20690

Zobrazit plný text záznamu

A multicenter pilot study of adjuvant docetaxel, epirubicin and cyclophosphamide (TEC) in patients (p) with stage II/III and node-positive breast cancer (BC)

Autor: M. J. Rubio, Isabel Alvarez, M. L. Gonzálvez, J. Valero, L. Heras, A. Yubero, A. Lorenzo, A. Modolell, I. Machengs-M Centelles-K Villadiego, J. Bayo, Jose I. Mayordomo

Publikováno v: Journal of Clinical Oncology. 25:11029-11029

11029 Background: Based on wide experience with docetaxel, adriamicin and cyclophosphamide (TAC regimen) for adjuvant therapy of node-positive BC but taking into account the high incidence of febrile neutropenia and mucositis, we performed the presen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1972db09a5f14671dd9011a0592d42e3
https://doi.org/10.1200/jco.2007.25.18_suppl.11029

Zobrazit plný text záznamu

A multicenter study of trastuzumab (H) and vinorelbine (N) as first and second line therapy for patients (pts) with HER2- positive metastatic breast cancer (HER2+ MBC)

Autor: Luis Cirera, J. Janáriz, E. Saigi, A. Arcusa, K. Villadiego, Miguel Ángel Seguí, R. M. Franquesa, M. Centelles

Publikováno v: Journal of Clinical Oncology. 23:868-868

868 Background: Combination therapy of Trastuzumab (H) and Vinorelbine (N) has recently been reported to be an active and safe regimen for HER2 positive MBC patients. We report here the preliminary...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ddf903ba3cd661d9daff3e5f4c591f0b
https://doi.org/10.1200/jco.2005.23.16_suppl.868

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání